Do you ever get the feeling the stock market isn’t reading the same news that you are? Compass Pathways(NASDAQ:CMPS) shareholders know that feeling. The clinical-stage drugmaker recently told investors its psilocybin-based treatment hit high marks in a…

Click here to view the original article.